WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Fireworks show held in Thailand's beach resort Pattaya to promote tourismChina's health literacy reaches 29.7 percent in 2023Ice blocks prepared for Harbin snow worldYanqing's top destinations to travel around in autumnChina introduces policies to facilitate citizens' travels overseasChina introduces policies to facilitate citizens' travels overseasCalifornia is joining with a New Jersey company to buy a generic opioid overdose reversal drugChina releases report on global meteorological development in 2023Tourism officials: Xinjiang a mustFlights and passengers to Harbin hit a record high